CoreBone Raises Funds for Bioactive Bone Graft

CoreBone Corals

CoreBone completed an investment round of $3.7 million. Funds will be used for extending CoreBone's commercial global presence, primarily in China. The Guangzhou Sino-Israel Biotech Investment Fund (GIBF), which focuses on introducing Israeli medical technologies to the Chinese market, invested $3 million in CoreBone's Chinese subsidiary; The...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us